GSK plc Investments Other Than Investments Accounted For Using Equity Method
GSK plc (GLAXF) had Investments Other Than Investments Accounted For Using Equity Method of GBP 2.13 billion as of 2021-12-31, per its 20-F filed 2022-03-08.
Discontinued › Notes
ifrs-full:InvestmentsOtherThanInvestmentsAccountedForUsingEquityMethod · last filed 2022-03-08
- 2021-12-31: Investments Other Than Investments Accounted For Using Equity Method 2.13B GBP.
- 2020-12-31: Investments Other Than Investments Accounted For Using Equity Method 3.06B GBP.
- 2019-12-31: Investments Other Than Investments Accounted For Using Equity Method 1.84B GBP.
- 2018-12-31: Investments Other Than Investments Accounted For Using Equity Method 1.32B GBP.
| Period end | Investments Other Than Investments Accounted For Using Equity Method |
|---|---|
| 2021-12-31 | 2.13B GBP 20-F · filed 2022-03-08 |
| 2020-12-31 | 3.06B GBP 20-F · filed 2022-03-08 |
| 2019-12-31 | 1.84B GBP 20-F · filed 2022-03-08 |
| 2018-12-31 | 1.32B GBP 20-F · filed 2021-03-12 |
| 2017-12-31 | 918.00M GBP 20-F · filed 2020-03-06 |
| 2016-12-31 | 985.00M GBP 20-F · filed 2019-03-15 |
| 2015-12-31 | 1.25B GBP 20-F/A · filed 2018-03-20 |